Thalassaemia: vizsgálatok itt: Libanon
3 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Where
- Hamra, Hazmiyeh, Tripoli
- Életkor
- 2 év and over
- People
- 480 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06609226 · EU 2024-510805-27-00 - 2. fázisTaking peopleStudy of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
- Where
- Beirut
- Életkor
- 6 év to 17 év
- People
- 99 worldwide
- Run by
- Celgene
See details and how to joinNCT04143724 · EU 2022-502499-22-00 - 3. fázisTaking peopleA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Hazmiyeh
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060